• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病的管理:当前新颖与被遗忘的疗法

Management of chronic kidney disease: The current novel and forgotten therapies.

作者信息

Pethő Ákos Géza, Tapolyai Mihály, Csongrádi Éva, Orosz Petronella

机构信息

Faculty of Medicine, Semmelweis University, Department of Internal Medicine and Oncology, Budapest, Hungary.

Medicine Service, Ralph H. Johnson VA Medical Center, Charleston, SC, USA.

出版信息

J Clin Transl Endocrinol. 2024 May 22;36:100354. doi: 10.1016/j.jcte.2024.100354. eCollection 2024 Jun.

DOI:10.1016/j.jcte.2024.100354
PMID:38828402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11143912/
Abstract

Chronic kidney disease (CKD) is a progressive and incurable condition that imposes a significant burden on an aging society. Although the exact prevalence of this disease is unknown, it is estimated to affect at least 800 million people worldwide. Patients with diabetes or hypertension are at a higher risk of developing chronic kidney damage. As the kidneys play a crucial role in vital physiological processes, damage to these organs can disrupt the balance of water and electrolytes, regulation of blood pressure, elimination of toxins, and metabolism of vitamin D. Early diagnosis is paramount to prevent potential complications. Treatment options such as dietary modifications and medications can help slow disease progression. In our narrative review, we have summarized the available therapeutic options to slow the progression of chronic kidney disease. Many new drug treatments have recently become available, offering a beacon of hope and optimism in CKD management. Nonetheless, disease prevention remains the most critical step in disease management. Given the significant impact of CKD on public health, there is a pressing need for further research. With the development of new technologies and advancements in medical knowledge, we hope to find more effective diagnostic tools and treatments for CKD patients.

摘要

慢性肾脏病(CKD)是一种渐进性且无法治愈的疾病,给老龄化社会带来了沉重负担。尽管这种疾病的确切患病率尚不清楚,但据估计全球至少有8亿人受其影响。糖尿病或高血压患者发生慢性肾脏损害的风险更高。由于肾脏在重要生理过程中起着关键作用,这些器官受损会扰乱水和电解质平衡、血压调节、毒素清除以及维生素D的代谢。早期诊断对于预防潜在并发症至关重要。饮食调整和药物等治疗选择有助于减缓疾病进展。在我们的叙述性综述中,我们总结了现有的减缓慢性肾脏病进展的治疗选择。最近有许多新的药物治疗可供使用,为慢性肾脏病的管理带来了希望和乐观的曙光。尽管如此,疾病预防仍然是疾病管理中最关键的一步。鉴于慢性肾脏病对公众健康的重大影响,迫切需要进一步研究。随着新技术的发展和医学知识的进步,我们希望能为慢性肾脏病患者找到更有效的诊断工具和治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/afa3bf94699a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/6be7b8afc86c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/314a3ff047ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/6f14f5a47001/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/477c5a1fb91f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/6653e8348fd1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/eb6fd7d8f619/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/afa3bf94699a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/6be7b8afc86c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/314a3ff047ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/6f14f5a47001/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/477c5a1fb91f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/6653e8348fd1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/eb6fd7d8f619/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9cb/11143912/afa3bf94699a/gr7.jpg

相似文献

1
Management of chronic kidney disease: The current novel and forgotten therapies.慢性肾脏病的管理:当前新颖与被遗忘的疗法
J Clin Transl Endocrinol. 2024 May 22;36:100354. doi: 10.1016/j.jcte.2024.100354. eCollection 2024 Jun.
2
Hemodialysis血液透析
3
Novel Therapeutic Approaches in the Management of Chronic Kidney Disease.慢性肾脏病管理中的新型治疗方法
Biomedicines. 2023 Oct 11;11(10):2746. doi: 10.3390/biomedicines11102746.
4
Tuberculosis结核病
5
6
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病(未透析)患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
7
Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review.非甾体类盐皮质激素拮抗剂与 2 型糖尿病相关的慢性肾脏病患者的高钾血症监测:一篇叙述性综述。
Postgrad Med. 2024 Mar;136(2):111-119. doi: 10.1080/00325481.2024.2316572. Epub 2024 Feb 16.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis.将达格列净在慢性肾脏病中的疗效转化为降低医疗资源利用和成本:一项医疗成本抵消分析。
J Med Econ. 2023 Jan-Dec;26(1):1407-1416. doi: 10.1080/13696998.2023.2264715. Epub 2023 Oct 31.
10
The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management.糖尿病与肾脏疾病之间的双向联系:机制与管理
Cureus. 2023 Sep 20;15(9):e45615. doi: 10.7759/cureus.45615. eCollection 2023 Sep.

引用本文的文献

1
Differential associations between synthetic endocrine disruptors and renal function impairment across varying degrees in middle-aged and older adult populations.中年及老年人群中不同程度的合成内分泌干扰物与肾功能损害之间的差异关联。
Front Public Health. 2025 Jul 10;13:1526070. doi: 10.3389/fpubh.2025.1526070. eCollection 2025.
2
Network-based machine learning reveals cardiometabolic multimorbidity patterns and modifiable lifestyle factors: a community-focused analysis of NHANES 2015-2018.基于网络的机器学习揭示了心血管代谢共病模式和可改变的生活方式因素:对2015 - 2018年美国国家健康与营养检查调查(NHANES)的社区聚焦分析
BMC Public Health. 2025 Jul 3;25(1):2297. doi: 10.1186/s12889-025-23483-9.
3
Aptamer-targeted anti-miR RNA construct based on 3WJ as a new approach for the treatment of chronic kidney disease in an experimental model.
基于三链连接体的适体靶向抗miR RNA构建体作为实验模型中治疗慢性肾病的新方法。
Gene Ther. 2025 Jun 14. doi: 10.1038/s41434-025-00544-7.
4
Shenfushu granules attenuate diabetic kidney disease by inhibiting /protein kinase B/heparanase-mediated endothelial-mesenchymal transition.参附舒颗粒通过抑制蛋白激酶B/乙酰肝素酶介导的内皮-间充质转化减轻糖尿病肾病。
World J Diabetes. 2025 May 15;16(5):102196. doi: 10.4239/wjd.v16.i5.102196.
5
Critical Review of the Benefit from Early Pharmacological and Dietary Support for Patients with Moderate-to-Severe (Non-Terminal) Chronic Kidney Disease.对中重度(非终末期)慢性肾病患者早期药物和饮食支持益处的批判性综述
Biomedicines. 2025 Apr 19;13(4):994. doi: 10.3390/biomedicines13040994.
6
The Effects of SGLT2 Inhibitors on Lipid Profile and Kidney Function in Patients with Chronic Kidney Disease Regardless of Diabetes and Hypertension Status.无论糖尿病和高血压状况如何,SGLT2抑制剂对慢性肾脏病患者脂质谱和肾功能的影响
Metabolites. 2025 Apr 13;15(4):271. doi: 10.3390/metabo15040271.
7
Molecular docking, dynamics simulations, and in vivo studies of gallic acid in adenine-induced chronic kidney disease: targeting KIM-1 and NGAL.腺嘌呤诱导的慢性肾病中没食子酸的分子对接、动力学模拟及体内研究:以KIM-1和NGAL为靶点
J Comput Aided Mol Des. 2025 Mar 15;39(1):11. doi: 10.1007/s10822-025-00590-8.
8
Global, regional, and national burden inequality of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年慢性肾脏病的全球、区域和国家负担不平等:全球疾病负担研究2021的系统分析
Front Med (Lausanne). 2025 Jan 15;11:1501175. doi: 10.3389/fmed.2024.1501175. eCollection 2024.
9
Artificial intelligence in predicting chronic kidney disease prognosis. A systematic review and meta-analysis.人工智能在预测慢性肾脏病预后中的应用。一项系统评价与Meta分析。
Ren Fail. 2024 Dec;46(2):2435483. doi: 10.1080/0886022X.2024.2435483. Epub 2024 Dec 11.
10
Care of Adults with Advanced Chronic Kidney Disease.晚期慢性肾脏病成人患者的护理
J Clin Med. 2024 Jul 26;13(15):4378. doi: 10.3390/jcm13154378.